Susquehanna International Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,357
Closed -$93K 5370
2019
Q4
$93K Sell
15,357
-57,180
-79% -$346K ﹤0.01% 3684
2019
Q3
$261K Sell
72,537
-67,247
-48% -$242K ﹤0.01% 3580
2019
Q2
$375K Buy
+139,784
New +$375K ﹤0.01% 3235
2019
Q1
Sell
-98,696
Closed -$156K 5161
2018
Q4
$156K Buy
98,696
+77,456
+365% +$122K ﹤0.01% 3049
2018
Q3
$78K Sell
21,240
-112,801
-84% -$414K ﹤0.01% 2995
2018
Q2
$379K Buy
134,041
+32,141
+32% +$90.9K ﹤0.01% 2490
2018
Q1
$378K Sell
101,900
-104,834
-51% -$389K ﹤0.01% 2347
2017
Q4
$595K Buy
206,734
+191,896
+1,293% +$552K ﹤0.01% 2253
2017
Q3
$67K Sell
14,838
-23,711
-62% -$107K ﹤0.01% 2939
2017
Q2
$177K Sell
38,549
-171,165
-82% -$786K ﹤0.01% 3115
2017
Q1
$883K Buy
209,714
+83,886
+67% +$353K ﹤0.01% 1791
2016
Q4
$520K Buy
125,828
+103,271
+458% +$427K ﹤0.01% 2926
2016
Q3
$183K Buy
+22,557
New +$183K ﹤0.01% 2595
2016
Q2
Sell
-122,620
Closed -$947K 4458
2016
Q1
$947K Sell
122,620
-70,243
-36% -$542K ﹤0.01% 2079
2015
Q4
$2.08M Sell
192,863
-445,125
-70% -$4.8M ﹤0.01% 1501
2015
Q3
$4.41M Sell
637,988
-3,813
-0.6% -$26.3K ﹤0.01% 938
2015
Q2
$5.69M Sell
641,801
-50,976
-7% -$452K ﹤0.01% 870
2015
Q1
$6.83M Buy
692,777
+572,687
+477% +$5.65M ﹤0.01% 665
2014
Q4
$1.47M Sell
120,090
-40,524
-25% -$496K ﹤0.01% 2209
2014
Q3
$1.6M Buy
160,614
+13,522
+9% +$135K ﹤0.01% 1910
2014
Q2
$1.11M Sell
147,092
-248,175
-63% -$1.88M ﹤0.01% 2314
2014
Q1
$1.3M Buy
395,267
+149,460
+61% +$492K ﹤0.01% 1877
2013
Q4
$816K Sell
245,807
-521,453
-68% -$1.73M ﹤0.01% 2407
2013
Q3
$2.32M Buy
767,260
+3,530
+0.5% +$10.7K ﹤0.01% 1379
2013
Q2
$6.25M Buy
+763,730
New +$6.25M ﹤0.01% 751